Genfit SA

GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and the 81st Scientific Sessions of the American Diabetes Association

23 Jun 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: June 15, 2021 Combined Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening

15 Jun 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Informs its Shareholders of Certain Procedures for the Combined General Meeting of June 15, 2021

27 May 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: Reports First Quarter 2021 Financial Information

12 May 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Provides Pipeline Update and Launch of New Clinical Programs

11 May 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Preparatory Documents

10 May 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered by GENFIT’s NIS4™ Technology to Identify Patients with At-Risk NASH

03 May 2021 02:10:00 By Nasdaq GlobeNewswire

GENFIT: Publication of the 2020 Universal Registration Document and the 2020 Annual Report on Form 20-F; Annual Shareholders Meeting to take place on June 15, 2021

23 Apr 2021 12:30:00 By Nasdaq GlobeNewswire

GENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members to its Executive Committee

22 Apr 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Reports Full-Year 2020 Financial Results and Provides Corporate Update

01 Apr 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT appoints Jean-François Tiné to the Board of Directors

04 Mar 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: Revenues and Cash Position as of December 31, 2020

26 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: new market research data highlight potential of elafibranor in PBC

22 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: 2021 Financial Calendar

10 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of Hepatology

09 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Two Key Appointments to the Executive Committee

28 Jan 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: Technical Corrections to the Results of the January 25, 2021 Bondholders Meeting with No Impact on Resolutions’ Approval

27 Jan 2021 15:30:00 By Nasdaq GlobeNewswire

GENFIT: Sweeping approval of OCEANEs buyback and amendments of terms

25 Jan 2021 13:30:03 By Nasdaq GlobeNewswire

GENFIT announces that its Extraordinary General Meeting on second notice will be held January 25, 2021 and informs the OCEANEs holders of certain procedures for the Bondholders’ Meeting of January 25, 2021

13 Jan 2021 16:10:00 By Nasdaq GlobeNewswire

January 13, 2021 Extraordinary Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening

12 Jan 2021 14:15:00 By Nasdaq GlobeNewswire